Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Get essential tips on what to consider when choosing a no annual fee rewards card. Ensure you get the best value.
18,552 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
U.S. investors will soon access perpetual futures, a cornerstone of the hottest crypto products world, under a new re...
The 2026 teen job outlook is grim, with hundreds teens flooding work as retailers and pools trim hiring. Experts warn...
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
As WWDC 2026 opens, Apple faces a pivotal moment: Tim Cook's leadership transition and a bold AI strategy that could ...
Goldman Sachs and MORGAN STANLEY are jockeying for the lead left role in a pair of AI IPOs, a $7 billion opportunity ...
Industry lenders are speeding toward AI-driven processes in reverse mortgage operations, but legal experts warn that ...
As investors seek higher income in a volatile market, high yield bonds attract attention. This explainer breaks down ...
Bitcoin trades under 65,000 as BEAT plunges 43%, drawing parallels to SIREN and weighing on the broader crypto market...
Summit Sotheby’s International Realty dominates Utah’s 2026 RealTrends Verified rankings, placing the most agents in ...
Meta's AI model projects Bitcoin reaching $150,000 by end-2026, citing halving dynamics, ETF flows, and macro tailwin...
Meta Platforms is advancing Arena, a stand-alone prediction markets app that would start with non-cash points and cou...